hgp1909
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jul 6, 2020 (NCT04652349)
Timeline
Indications
Mechanism of action
HSP90AB2P inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04762407 | Phase 1 | Nov 20, 2020 | Hanmi Pharmaceutical |
| NCT04652349 | Phase 3 | Jul 6, 2020 | Hanmi Pharmaceutical |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hanmi Pharmaceutical | For profit | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1